 |
University of Fukui
| University of Fukui, Faculty of Medical Sciences
| University of Fukui Hospital (Japanese) |
 |
|
 |


|
|
|
 |
HOME >Staff |
 |
|
|
|
|
Yasushi Kiyono, PhD |
|
Professor, Molecular Imaging Division |
|
|
|
 |
 |
Development and evaluation of new molecular imaging probes for PET |
 |
My interest is in visualizing the changes in our body non-invasively using molecular imaging probes. I have been developing new molecular imaging probes to image cardiac sympathetic nervous function and noradrenergic nervous function in the brain. Now I am starting to develop new tumor imaging probes and probes for internal radiation therapy.
|
|
|
|
Munenobu Nogami, MD, PhD |
|
Associate Professor, Medical ImagingDivision |
|
|
|
 |
 |
Development of molecular imaging and hybrid imaging in oncology |
 |
I am conducting clinical research using hybrid imaging, which is a combination of different imaging modalities such as PET and CT or MRI. In particular, my activity is focused on developing a new imaging method using integrated and simultaneous PET/MRI system, which combines PET with various tracers (molecular probes) and MRI with both functional and morphological imaging. |
|
|
|
|
|
Akira Makino, PhD |
|
Associate Professor, Molecular Imaging Division |
|
|
|
 |
 |
Development and evaluation of new molecular imaging probes for PET |
 |
New molecular imaging probes, which utilize specific characters of the targeted diseases, will be developed. Molecular probe candidate compounds combined with the features of various modalities such as PET, SPECT, MRI, and near-infrared fluorescence (NIRF), will be created making full use of synthetic chemistry techniques. By cyclical consideration of molecular design, chemical synthesis, and biological evaluation of the candidate compounds, I am trying to develop a probe which leads to the establishment of a new diagnostic method. |
|
|
|
|
Tetsuya Mori, PhD |
|
Assistant Professor, Radiopharmaceutical Chemistry Division |
|
|
|
 |
 |
|
 |
I am engaged in the research on radiopharmaceutical chemistry: synthesis, in vitro and in vivo evaluation of novel molecular probes for PET imaging. In addition, I am trying to develop an original automatic synthesis module. I am also involved in the production and quality control of radiopharmaceuticals for clinical PET studies.. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
. |
 |
. |
|
|
|
Panasonic Medicalengineering Collaborative Division |
|
|
|
Kenji Kondo |
|
Invited Associate Professor |
|
|
|
|
 |
|
 |
|
|
|
|
Toyohiko Sakai, MD |
|
Associate Professor, Department of Radiology |
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
Research Collaborators (Univ. Fukui) |
|
|
|
Tatsuya Asai, PhD |
|
Associate Professor, Image Engineering Divsion (Associate Professor, Faculty of Engneering) |
|
|
|
 |
 |
The functions of various ion channels, water channels (aquaporin), transporters on the neuronal excitation and the signal transmission at synapses. |
 |
After moving to the newly-established Department of Nuclear Power and Energy Safety Engineering, I have been collaborating with researchers at the Biomedical Imaging Research Center. I would like to combine the molecular imaging technique using position nucleotides with the optical imaging technique to exploit new research areas. |
|
|
|
Minyoung Jung, PhD |
|
Korean Brain Research Institute (Specially-appointed Professor, Department of Psychiatry) |
|
|
|
 |
 |
|
 |
|
|
|
|
|
|
|
|
|
Students & Post-doctoral Fellow |
|
|
|
Rikiya Maruyama, RT |
|
Graduate Student Faculty of Medical Sciences , PhD Course |
|
|
|
 |
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
Medical Imaging, Clinical Research |
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
Basic Research |
 |
|
|
|
|
|
|
|
Kunieda M |
|
Master course Student (Department of Engineering) |
|
|
|
|
 |
|
 |
|
|
|
|
Manabe T, Murata M |
|
Master course Student (Department of Engineering) |
|
|
|
|
 |
|
 |
|
|
|
|
Research Collaborators (Other Institutes) |
|
|
|
Yukie Yoshii, PhD |
|
Visiting Researcher ,National Institute of Radiological Sciences |
|
|
|
 |
 |
Metabolic analysis of protist and animal cells - How have mitochondria evolved? - |
 |
I have studied on evolution of protosynthesis in eukaryotes in University of Tsukuba until 2004 June and then moved to BIRC, University of Fukui. I am interested in evolution of eukaryotes and their symbiotic evolution. My recent research subject is metabolic analysis of ptotist and animal cells and the evolutionary implication. |
|
|
|
|
Masato Kobayashi, PhD |
|
Assistant Professorr, Kanazawa University |
|
|
|
 |
 |
Brain functional imaging using PET |
 |
|
|
|
|
|
Secretary・Research Assistant |
|
|
Hiroshi Oikawa |
|
Research Technologist |
|
|
|
|
|
 |
|
|
|
|
Yumiko Kurokawa |
|
Research Technician |
|
|
|
|
|
 |
PET reception, RI management, Clinical study assistance
Birth Place: Hikone, Shiga, Japan
Hobby: Driving, Puzzles |
|
|
|
Miyuki Yabu |
|
Research Technician |
|
|
|
|
|
 |
|
|
|
|
Kaori Yamaguchi |
|
Secretary |
|
|
|
|
|
 |
|
|
|
|
|
Yuki Okamoto |
|
Secretary |
|
|
|
|
|
 |
|
|
|
|
Etsuko Mizuguchi |
|
Secretary |
|
|
|
|
|
 |
|
|
|
|
Martinez Miguel Ernesto, PhD. |
|
CMI. Inc. |
|
|
|
 |
Development of F-18 radiopharmaceutical for PET imaging of infections. |
 |
Development of more efficient and less time-consuming reactions to synthesize new PET radiotracers is a challenge for radiochemists due to the short half-lives of positron-emitting radioisotopes. Aminosugars labeled with positron-emitting radioisotopes have been investigated for the in-vivo evaluation of biochemical processes in cancerous tissue. Since aminosugars are obligatory structural components of many biologically important macromolecules including glycoproteins and polysaccharides, they could also be used for imaging infection using PET. The aim of my research is to develop aminosugar labeled compounds which will contribute to progress in PET imaging of infections. |
|
|
|
|
Visiting Professors |
|
|
|
|
Makoto Yoneda, MD, PhD |
|
Visiting Professor, Fukui Prefectural University |
|
|
|
 |
 |
|
 |
|
|
|
|
Takako Furukawa, PhD |
|
Visiting Professor, Molecular Imaging Division (Team Leader, NIRS) |
|
|
|
 |
 |
|
 |
The rapid advance in molecular and cellar biology has brought us ever growing knowledge of molecular events underlying physiological and pathological changes in our body and enabled new types of therapy directly targeting the molecular events. My interest is in visualizing the changes in our body non-invasively using radiolabeled probes at the molecular level, typically as the changes in gene expression, to realize the quicker and more accurate diagnosis and to choose effective therapy protocols, as well as to further deepen our understanding of the mechanisms supporting our life. |
|
|
|
Keiichi Kawai, PhD |
|
Visiting Professor, Radiopharmaceutical Chemistry Division (Professor, Kanazawa Univ.) |
|
|
|
|
 |
Design and Evaluation of New Radiopharmaceuticals for Functional Diagnosis and Tumor Therapy, Pharmacokinetic Regulation |
 |
The main purpose of my research is the development of novel radiopharmaceuticals for noninvasive imaging of physiological and/or biochemical function. I have been designed and evaluated new radiolabeled compounds, mainly metabolic substrate derivatives, in order to visualize metabolic and neuronal function using molecular imaging approaches. The development of tumor imaging and therapeutic agents are also approved. I am investigating pharmacokinetic regulation methods by DDS technique. |
|
|
|
Kazutaka Yamamoto MD, PhD |
|
Visiting Professor, Oncology Division (Associate Professor, Shool of Medicine) |
|
|
|
|
 |
|
 |
|
|
|
|
Tatsuo Ido, PhD |
|
Visiting Professor, Molecular Imaging Division |
|
|
|
 |
 |
|
 |
|
|
|
|
Past Directors |
|
|
|
|
Yoshiharu Yonekura, MD, PhD |
|
(1998.4 - 2006.3) Emeritus Professor |
|
|
|
 |
|
 |
|
|
|
|
Yasushi Ishii, MD, PhD |
|
(1994.5 - 1998.3) Emeritus Professor |
|
|
|
 |
|
 |
|
|
|